Literature DB >> 3981718

Xanthine-containing calculi during allopurinol therapy.

S Kranen, D Keough, R B Gordon, B T Emmerson.   

Abstract

We report a case of urate overproduction owing to the Lesch-Nyhan syndrome (deficiency of hypoxanthine-guanine phosphoribosyltransferase). Urate crystalluria was controlled by allopurinol therapy but renal calculi developed, which contained a variety of purines, particularly the relatively insoluble xanthine, as well as oxypurinol and hypoxanthine. The potential hazard from the increased amounts of xanthine that are produced during allopurinol therapy for urate overproduction is stressed, as well as the importance of maintaining a high urine flow rate even during such therapy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3981718     DOI: 10.1016/s0022-5347(17)49133-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Acute renal failure due to bilateral xanthine urolithiasis in a boy with Lesch-Nyhan syndrome.

Authors:  Przemysław Sikora; Monika Pijanowska; Marek Majewski; Beata Bieniaś; Halina Borzecka; Małgorzata Zajczkowska
Journal:  Pediatr Nephrol       Date:  2006-05-24       Impact factor: 3.714

Review 2.  Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

Authors:  Michel Daudon; Vincent Frochot; Dominique Bazin; Paul Jungers
Journal:  Drugs       Date:  2018-02       Impact factor: 9.546

Review 3.  Drug-induced renal calculi: epidemiology, prevention and management.

Authors:  Michel Daudon; Paul Jungers
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 4.  Nephrolithiasis related to inborn metabolic diseases.

Authors:  Pierre Cochat; Valérie Pichault; Justine Bacchetta; Laurence Dubourg; Jean-François Sabot; Christine Saban; Michel Daudon; Aurélia Liutkus
Journal:  Pediatr Nephrol       Date:  2009-01-21       Impact factor: 3.714

5.  Xanthine calculi in a patient with Lesch-Nyhan syndrome and factor V Leiden treated with allopurinol: case report.

Authors:  Lisa B E Shields; Dennis S Peppas; Eran Rosenberg
Journal:  BMC Pediatr       Date:  2018-07-12       Impact factor: 2.125

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.